Auranofin enhances phosphorylation of putative substrates of protein kinase C in human platelets
- 15 January 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (2) , 366-368
- https://doi.org/10.1016/0006-2952(88)90745-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Inhibition of epidermal growth factor binding to HeLa cells by auranofinBiochemical Pharmacology, 1987
- Cellular and molecular pharmacology of auranofin and related gold complexesBiochemical Pharmacology, 1986
- Studies and Perspectives of Protein Kinase CScience, 1986
- Auranofin affects early events in human polymorphonuclear neutrophil activation by receptor-mediated stimuli.The Journal of Immunology, 1984
- The role of protein kinase C in cell surface signal transduction and tumour promotionNature, 1984
- Platelet Ca2+-activated, phospholipid-dependent protein kinase: Evidence for proteolytic activation of the enzyme in cells treated with phospholipase CBiochemical and Biophysical Research Communications, 1984
- Auranofin versus placebo in the treatment of rheumatoid arthritisThe American Journal of Medicine, 1983
- Synergistic functions of phorbol ester and calcium in serotonin release from human plateletsBiochemical and Biophysical Research Communications, 1983
- Studies of the effect of auranofin, a new antiarthritic agent, on platelet aggregationInflammation, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970